DDX5: a versatile RNA helicase in cancer and cell fate determination—linking c-Myc and JAK2 V617F signalling to emerging therapeutics

View at publisher Summarise with VIRAT
Authors: Kenji Tago, Megumi Funakoshi‐Tago
Cited by: 0
References: 52

Summary

No summary yet. VIRAT can read this paper and write a plain-language summary of its aim, methods, key findings and limitations.

Summarise with VIRAT Free to try with your Science Catalogs account.

Abstract

Traditionally regarded as a DEAD-box RNA helicase involved in RNA metabolism, DDX5 (also known as p68) has emerged as a signal-responsive regulator that integrates RNA processing with transcriptional control, thereby influencing cell fate determination and tumourigenesis. Beyond its canonical roles in pre-mRNA splicing, ribosome biogenesis, microRNA maturation and R-loop resolution, DDX5 also functions in a helicase-independent manner as a transcriptional co-activator for diverse transcription factors and signalling pathways. Recent studies have revealed a dichotomy in which the RNA helicase activity and scaffolding/co-activator functions of DDX5 are selectively deployed in a context-dependent manner. In cancer, DDX5 enhances the transcriptional activity and transforming capacity of the proto-oncogene c-Myc and is itself transcriptionally induced by c-Myc, forming a positive feedback loop that sustains oncogenic transcriptional programs. DDX5 is also indispensable for transformation driven by the constitutively active JAK2 V617F mutant, a major driver of myeloproliferative neoplasms, where it promotes malignant signalling largely independently of its RNA helicase activity. In contrast, during adipocyte differentiation, the helicase function of DDX5 is essential for glucocorticoid receptor transcriptional programs. Importantly, recent studies have identified the small-molecule compound FL118 as a potent DDX5 degrader, providing proof of concept that targeting DDX5 protein stability represents a promising therapeutic strategy.

Fields of Study & Subjects

RNA Research and Splicing Genomics and Chromatin Dynamics Cancer-related Molecular Pathways

Publication details

Journal / source
The Journal of Biochemistry
Volume
180
Issue
1
Pages
1–10
Publication date
25 March 2026
Language
EN